Replimune Group, Inc. (REPL) Key Metrics

NASDAQ: REPLValuation, returns, debt and efficiency ratios over 10 years.

REPL valuation today

Trailing 12 months · as of October 17, 2026
Market cap
$1.02B
Enterprise value
$1.14B
P/E (TTM)
—
Forward P/E
—
PEG ratio
—
Price / sales
—
Price / book
11.6
10-yr median 2.0
EV / EBITDA
—
Dividend yield
—
Beta
0.94

REPL key metrics, FY2017–FY2026

Fiscal year ended March 31, 2026 · U.S. dollars

REPL valuation Price multiples at each fiscal year-end price.

Price / book+126.2%
4.3
FY2026 · hover or tap a bar for each year
FY2019: 2.6FY2020: 1.9 (−27.4%)FY2021: 2.8 (+52.2%)FY2022: 2.2 (−23.8%)FY2023: 1.9 (−14.1%)FY2024: 1.5 (−21.6%)FY2025: 1.9 (+30.1%)FY2026: 4.3 (+126.2%)
FY2017FY2026
Free cash flow yield−14.8 pts
−40.1%
FY2026 · hover or tap a bar for each year
FY2019: −7.9%FY2020: −19.6% (−11.7 pts)FY2021: −4.5% (+15.1 pts)FY2022: −9.5% (−5.0 pts)FY2023: −12.7% (−3.1 pts)FY2024: −35.1% (−22.5 pts)FY2025: −25.3% (+9.8 pts)FY2026: −40.1% (−14.8 pts)
FY2017FY2026

REPL valuation history

Fiscal year-endToday10-year median

REPL returns on capital

ROEROICROA

Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.

REPL debt vs cash

Total debtCash & short-term investments

Debt includes short- and long-term borrowings and, where reported, lease liabilities.

REPL cash returned to shareholders

DividendsBuybacksFree cash flow

REPL price vs earnings per share

Share price at year-endEPS (right axis)

REPL key metrics

FY2017–FY2026
Replimune Group, Inc. key metrics by fiscal year
FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Valuation
Market capitalization$709.9M$785.5M$543.9M$1.03B$886.6M$1.41B$341.6M$353.1M——
Enterprise value$552.6M$377.9M$199.1M$505.4M$523.7M$968.0M$214.8M$224.8M——
Price / book4.31.91.51.92.22.81.92.6——
Earnings yield−44.2%−31.5%−39.7%−17.0%−13.3%−5.7%−15.4%−8.7%——
Free cash flow yield−40.1%−25.3%−35.1%−12.7%−9.5%−4.5%−19.6%−7.9%——
Dividend yield—————6.5%8.2%———
Shareholder yield (dividends + buybacks)———0.0%—6.5%8.2%0.0%——
Share price at fiscal year-end$7.65$9.75$8.17$17.66$16.98$30.51$9.97$15.22——
Per share
Revenue per share$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Earnings per share−$3.38−$3.07−$3.24−$2.99−$2.26−$1.75−$1.54−$1.33−$0.64−$0.25
Operating cash flow per share−$3.02−$2.39−$2.79−$2.20−$1.57−$1.33−$1.77−$1.09−$0.52−$0.23
Free cash flow per share−$3.07−$2.47−$2.87−$2.24−$1.62−$1.38−$1.96−$1.21−$0.52−$0.24
Cash per share$2.90$6.01$6.32$10.02$7.58$10.30$4.92$5.81$2.00$0.67
Book value per share$1.79$5.16$5.63$9.54$7.88$10.78$5.36$5.94−$0.91−$0.37
Tangible book value per share$1.79$5.16$5.63$9.54$7.88$10.78$5.36$5.94−$0.91−$0.37
Dividends per share—————$1.98$0.82———
Capex per share$0.05$0.08$0.09$0.04$0.04$0.05$0.19$0.11$0.00$0.01
Debt per share$1.20$0.95$1.14$1.04$0.63$0.72$1.22$0.28——
Shares outstanding92.8M80.6M66.6M58.2M52.2M46.2M34.3M23.2M30.8M30.8M
Change in shares outstanding+15.2%+21.0%+14.4%+11.5%+12.9%+35.0%+47.7%−24.8%0.0%—
Returns & profitability
Return on equity (ROE)−107.9%−62.6%−46.4%−36.1%−25.9%−23.7%−32.7%−56.2%——
Return on invested capital (ROIC)——−594.7%−345.1%−184.4%−116.1%−133.4%———
Return on assets (ROA)−71.0%−47.6%−38.0%−31.5%−23.5%−20.8%−27.1%−28.1%−44.8%−33.8%
Return on tangible assets−94.4%−44.9%−44.2%−27.0%−25.6%−14.9%−22.5%−20.0%−30.2%−33.8%
Financial health
Total debt$111.6M$76.2M$75.9M$60.8M$32.8M$33.3M$41.8M$6.6M——
Cash & short-term investments$268.9M$483.8M$420.7M$583.4M$395.7M$476.3M$168.6M$134.8M$61.6M$20.6M
Net debt−$157.3M−$407.6M−$344.8M−$522.6M−$362.8M−$443.0M−$126.8M−$128.2M−$61.6M−$20.6M
Debt / equity0.670.180.200.110.080.070.230.05——
Debt / assets0.340.140.160.090.070.060.180.04——
Current ratio4.797.9510.7217.5219.4633.2514.6814.2612.5311.29
Quick ratio4.797.9510.7217.5219.4633.4614.9214.2612.5311.29
Interest coverage-36.1-33.1-35.3-42.6-54.6-27.0-29.3———
Working capital$220.9M$433.5M$393.2M$558.8M$383.2M$469.2M$162.4M$131.1M$59.5M$20.4M
Invested capital$8.9M$8.2M$29.7M$32.7M$48.4M$55.7M$57.0M$9.6M−$89.6M−$32.1M
Tangible asset value$166.2M$415.8M$374.5M$555.3M$411.2M$498.7M$183.7M$137.9M−$28.1M−$11.5M
Net current asset value$112.9M$360.4M$320.5M$501.3M$354.0M$439.4M$123.9M$124.5M−$28.5M−$11.9M
Graham net-net per share$1.12$4.36$4.67$8.49$6.66$9.36$3.47$5.18−$0.97−$0.41
Capital allocation
Dividends paid—————$91.7M$28.1M———
Share buybacks (net)———$0—$0$0$0$0$0
Capex / depreciation1.271.912.130.931.091.4012.2717.571.251.95
Efficiency
Days of inventory on hand—————-260.8-598.3———
Days payables outstanding—783.8545.9678.4242.8255.31,062.311,192.93,877.7966.4
Receivables turnover0.000.000.000.000.000.000.000.000.000.00
Payables turnover—0.470.670.541.501.430.340.030.090.38
Asset turnover0.000.000.000.000.000.000.000.000.000.00
Average receivables$2.7M$4.3M$3.9M$3.0M$3.0M$3.0M$2.7M$2.4M$1.9M$1.4M
Average payables$9.6M$7.5M$4.0M$4.5M$3.0M$2.9M$5.3M$4.5M$1.2M$323,000
Average inventory—————−$3.0M−$3.0M———
Intangibles / total assets0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%

Computed from REPL's annual financial statements (latest annual report filed June 29, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.

REPL valuation and financial ratios

Replimune earned a return on equity of −107.9% in fiscal 2026. It ended the year with $111.6 million of debt and $268.9 million in cash and short-term investments, a net cash position of $157.3 million. The share count rose 200.9% from 30.8M to 92.8M over 9 years.

See the REPL income statement, the REPL chart for price history, or the REPL stock overview for the latest quote and news.

REPL key metrics FAQ

What is Replimune's return on equity?

Replimune's return on equity (ROE) was −107.9% in fiscal 2026: net income of -$313.9 million on average shareholders' equity of $291.0 million.

How much debt does Replimune have?

Replimune had total debt of $111.6 million at the end of fiscal 2026, a debt-to-equity ratio of 0.67 and more cash than debt.

What is Replimune's free cash flow yield?

Replimune generated -$284.6 million of free cash flow in fiscal 2026, a free cash flow yield of −40.1% on its market value at year-end ($709.9 million).

What is Replimune's current ratio?

Replimune's current ratio was 4.79 at the end of fiscal 2026: current assets were 4.79 times current liabilities.

Biotechnology key metrics